1. Home
  2. PGEN vs VCIC Comparison

PGEN vs VCIC Comparison

Compare PGEN & VCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • VCIC
  • Stock Information
  • Founded
  • PGEN 1998
  • VCIC 2024
  • Country
  • PGEN United States
  • VCIC United States
  • Employees
  • PGEN N/A
  • VCIC N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • VCIC
  • Sector
  • PGEN Health Care
  • VCIC
  • Exchange
  • PGEN Nasdaq
  • VCIC NYSE
  • Market Cap
  • PGEN 292.6M
  • VCIC 293.0M
  • IPO Year
  • PGEN N/A
  • VCIC 2024
  • Fundamental
  • Price
  • PGEN $0.74
  • VCIC $10.03
  • Analyst Decision
  • PGEN Buy
  • VCIC
  • Analyst Count
  • PGEN 5
  • VCIC 0
  • Target Price
  • PGEN $7.00
  • VCIC N/A
  • AVG Volume (30 Days)
  • PGEN 1.1M
  • VCIC 6.1K
  • Earning Date
  • PGEN 11-14-2024
  • VCIC 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • VCIC N/A
  • EPS Growth
  • PGEN N/A
  • VCIC N/A
  • EPS
  • PGEN N/A
  • VCIC N/A
  • Revenue
  • PGEN $3,963,000.00
  • VCIC N/A
  • Revenue This Year
  • PGEN N/A
  • VCIC N/A
  • Revenue Next Year
  • PGEN $402.12
  • VCIC N/A
  • P/E Ratio
  • PGEN N/A
  • VCIC N/A
  • Revenue Growth
  • PGEN N/A
  • VCIC N/A
  • 52 Week Low
  • PGEN $0.65
  • VCIC $9.96
  • 52 Week High
  • PGEN $1.93
  • VCIC $10.03
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 43.78
  • VCIC N/A
  • Support Level
  • PGEN $0.71
  • VCIC N/A
  • Resistance Level
  • PGEN $0.78
  • VCIC N/A
  • Average True Range (ATR)
  • PGEN 0.05
  • VCIC 0.00
  • MACD
  • PGEN 0.01
  • VCIC 0.00
  • Stochastic Oscillator
  • PGEN 49.28
  • VCIC 0.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About VCIC VINE HILL CAP INVT CORP

Vine Hill Capital Investment Corp is a blank check company.

Share on Social Networks: